On-Demand Webinar 


Fight Against COVID-19 Webinar Series

Automated Nucleic Acid Testing and Full-genome Sequencing of SARS-CoV-2








MGI has been at the forefront of the battle against the COVID-19 pandemic from the very beginning. Since February 2020, MGI has been helping global customers (including hospitals and disease control centers) to rapidly expand their nucleic acid testing capacity while delivering new products, including ATOPlex RNA Library Prep Set, MGISP-NE384 High-throughput Automated Nucleic Acid Extractor, and MGI Automated & Integrated Mobile Testing Laboratory. This webinar series also shares valuable user experience by inviting Dr. Monta Ustinova from Latvian Biomedical Research and Study Centre, Camila Guindalini from Fiocruz, and Dr. Željka Trepotec, Molecular Biologist at Onkologisches Zentrum Freising, to describe how MGI's instruments and solutions contribute to the fight.



Mobile Platforms Total Solution for Automated & Integrated Nucleic Acid Testing

- Benny Zhida Chen, MGI Project Manager

  • - Xiongfei Li, MGI Project Manager

  • To better control and end the pandemic soon, MGI provides new mobile platform solutions to quickly increase nucleic acid testing capability. Two MGI's Project Managers would bring you a closer look at different throughput solutions and share some real case studies.



ATOPlex Multiplex PCR Panel COVID-19

  • - Dr. Yao Jiang, MGI senior product manager 

    - Dr. Monta Ustinova, Latvian Biomedical Research and Study Centre Research Assistant 

ATOPlex is a MPS solution that applies MGI proprietary ultra-high multiplex PCR-based enrichment technique in customized panel design. It provides a streamlined workflow for complete genome sequencing and epidemiological study of COVID-19. 



Fighting COVID-19 in the Laboratory - Large Scale Testing Strategies in Brazil

  • - Camila Guindalini, Fiocruz Senior Scientist

The Oswaldo Cruz Foundation (Fiocruz) is one of the most important public health institutions in Brazil. The Fiocruz's Covid-19 Diagnostic Support Unit uses real-time PCR methodology and MGI SARS-CoV-2 Automated Extraction Solutions, along with 11 robots, to guarantee the speed and precision of 15,000 results daily. 



Highly Sensitive and Full-genome Sequencing of SARS-CoV-2 Using Multiplex PCR Enrichment Followed by MPS

- Dr. Ravi Kumar Chilukoti, Head of India Technical Support at MGI

We are very happy to bring you Dr. Ravi Kumar Chilukoti from MGI India to share with you ATOPlex Multiplex PCR-based research.



MGI's Automated Sample Processing for COVID-19 Testing - MGISP-NE384 New Product Launch

- Dr. Alessandro Angerilli, MGI Field Application Scientist

- Dr. Željka Trepotec, Molecular Biologist at Onkologisches Zentrum Freising

MGISP-NE384 is MGI's high-throughput automated nucleic acid extractor adopting magnetic rod technology. Watch this webinar for more details on its workflow and early user experience!



  • Fill the form to watch the five on-demand webinars.